Jordan Collaborating Cardiology Group
26
2
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
30.8%
8 terminated/withdrawn out of 26 trials
55.6%
-31.0% vs industry average
12%
3 trials in Phase 3/4
10%
1 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (26)
How Often Does the Fecal Test for Occult Blood Turn Positive After Using Blood Thinners?
Role: lead
Incidental Findings on Coronary Computed Tomography Angiography
Role: lead
The Cardiovascular-Renal-Metabolic (CRM) Syndrome Survey in Jordan
Role: lead
Cardiovascular Risk Factors in Middle Eastern Patients With Stroke
Role: lead
Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents
Role: lead
Iron Deficiency in Patients With Heart Failure and Reduced and Mildly Reduced Ejection Fraction
Role: lead
Screening for Obstructive Sleep Apnea in Medical Patients
Role: lead
Thyroid Profiles in Patients With Acute Illness
Role: lead
Cardiovascular Patients With no Standard Modifiable Risk Factors
Role: lead
Clinical Association Between Obstructive Sleep Apnea, Facial Pigmentation, and Vasovagal Symptoms.
Role: lead
Tracking of Lipid Lowering Therapy in Jordan
Role: lead
Cardiovascular Risk Categories and Attaining LDL-C Targets in Middle Eastern Adults Aged 30-55 Years of Age
Role: lead
Risk Factors in Young Middle Eastern Women With Cardiovascular Disease
Role: lead
Myocardial Infarction Triggers and Onset in Jordan Study 2
Role: lead
Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVR
Role: lead
Atrial Fibrillation Registry in Jordan
Role: lead
Surviving a Decade or More After Coronary Revascularization in a Middle Eastern Population
Role: lead
Acute Cardiovascular Events Triggered by COVID-19-Related Stress
Role: lead
Effect of Low Dose ColchiciNe on the InciDence of POAF
Role: lead
Statin Eligibility Prior to Myocardial InfarCtion
Role: lead